Article
Allogene shares sink on early look at an 'off the shelf' CAR-T for myeloma
Rating:
0.0
Views:
69
Likes:
1
Library:
1
Results the company will present at a medical meeting, while early, don't appear to meet the high bar set by rival CAR-T cell therapies from Bristol Myers Squibb and Johnson & Johnson.
Rate This Post
-
Education
-
Communication
-
Entertainment
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value